Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Allergy and Infectious Diseases (NIAID)
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients must have:
Absence of HIV-1 infection as documented by any licensed ELISA test kit within 14 days prior to study entry.
You may not be if
Co-existing Condition:
Patients with the following symptoms and conditions are excluded:
Any medical condition that, in the opinion of the investigator, would interfere with the patient's ability to participate in this protocol.
Patients with the following prior conditions and symptoms are excluded:
History of chronic illness such as hypertension, coronary artery disease, arthritis, diabetes, or any chronic gastrointestinal conditions that might interfere with drug absorption.
Clareo Health | The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir
